Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 23Myelodysplastic Syndromes 22Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Non-Hodgkin 17Multiple Myeloma 15Lymphoma 14Hodgkin Disease 13Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Lymphoma, Mantle-Cell 10Lymphoma, Follicular 10Congenital Abnormalities 10Lymphoma, B-Cell, Marginal Zone 9Burkitt Lymphoma 9Lymphoma, Large B-Cell, Diffuse 8Anemia, Refractory, with Excess of Blasts 8Neoplasms, Plasma Cell 7Myeloproliferative Disorders 7Hematologic Neoplasms 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Accelerated Phase 6Blast Crisis 6Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Myelomonocytic, Chronic 5Graft vs Host Disease 5Sezary Syndrome 4Mycosis Fungoides 4

Interventions

Antilymphocyte Serum 5Mycophenolic Acid 4Cyclosporine 4Cyclophosphamide 4Cord Blood Stem Cell Transplantation 4Radiotherapy 3Filgrastim 3Busulfan 3fludarabine phosphate 2Tacrolimus 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Moxifloxacin 2Methylprednisolone 2Methotrexate 2Melphalan 2Flow Cytometry 2Etoposide 2Amplified Fragment Length Polymorphism Analysis 2thymoglobulin 1Whole-Body Irradiation 1Tetradecanoylphorbol Acetate 1Stem Cell Transplantation 1Sirolimus 1Polymerase Chain Reaction 1Oxycodone 1Morphine 1Methadone 1Immunosuppression Therapy 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pdgfra-Associated Chronic Eosinophilic Leukemia × Whole-Body Irradiation × Clear all
NCT00719849 2017-06-14

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

Fred Hutchinson Cancer Center

Phase 2 Terminated
13 enrolled 24 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Polycythemia Vera, Recurrence, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡